Summary: Using state-of-the-art cryo-electron microscopy, researchers captured atomic-resolution snapshots that reveal how glutamate, the brain’s primary excitatory neurotransmitter, triggers the opening of AMPA receptor channels. These channels control the flow of charged ions between neurons, underpinning learning, memory and many forms of synaptic signaling, and are implicated in disorders such as epilepsy.
The study demonstrates that glutamate functions like a molecular key: when it binds, the receptor’s ligand-binding domain closes in a clamshell-like motion that pulls open the ion channel, allowing cations to flow into the neuron. These mechanistic details provide a clearer blueprint for designing drugs that could modulate AMPA receptor activity in neurological and cognitive disorders.
Key Facts:
- Molecular mechanism: Glutamate binding causes a clamshell-like closure of the AMPA receptor’s ligand-binding domain, translating into opening of the ion channel pore.
- Imaging breakthrough: More than one million cryo-EM images were collected and analyzed to resolve receptor states at near-atomic resolution.
- Therapeutic potential: Detailed structural insights can inform drug design to either potentiate or inhibit AMPA receptor activity, relevant to epilepsy and cognitive disorders.
Source: JHU
Overview: To better understand how neurons communicate chemically, researchers led by Johns Hopkins Medicine used cutting-edge cryo-electron microscopy to visualize, at atomic detail, the moment glutamate activates AMPA-type ionotropic glutamate receptors (AMPARs). These receptors form ion channels that, when opened by glutamate, allow positively charged ions to enter the postsynaptic cell and initiate electrical signaling. The findings were published in Nature and represent a significant advance in linking structural motion to receptor function.
The research team focused on capturing AMPAR conformations during the sequence of events that follow glutamate exposure. Unlike many structural studies performed at cryogenic temperatures to stabilize samples, the investigators prepared receptors at physiological temperature (approximately 37°C) before rapidly freezing them for cryo-EM imaging. This approach preserved dynamic states that are enhanced at body temperature and allowed visualization of activation steps that are harder to detect when receptors are chilled.
Receptors were purified from commonly used human embryonic cell lines and briefly heated to physiological temperature. Immediately after exposing the receptors to glutamate, the samples were flash-frozen to trap transient conformations and then imaged. By assembling and analyzing over a million cryo-EM images, the researchers reconstructed the sequence in which ligand binding leads to channel opening.
The images show glutamate binding within the receptor’s ligand-binding domain, provoking a clamshell-like closure that transmits force to the transmembrane helices. Those helices hinge outward from the pore axis, widening the channel and enabling cation influx. Conversely, receptor desensitization involves dimer interface rearrangement that allows the channel gate to return to a closed conformation.
These mechanistic insights align with prior work from the team showing how certain antiseizure drugs, such as perampanel, act like a physical barrier that prevents full channel opening. Understanding the precise motions and contact points involved in gating opens opportunities to create molecules that selectively stabilize open, closed, or desensitized states of AMPARs—an avenue that could lead to improved treatments for epilepsy and cognitive impairments.
“Each structural snapshot adds a critical piece to the puzzle of how synaptic transmission works,” says Edward Twomey, Ph.D., assistant professor of biophysics and biophysical chemistry at Johns Hopkins University School of Medicine and lead author on the study. These data help bridge the gap between molecular structure and neuronal function, informing both basic neuroscience and translational drug development.
Contributors to the study include researchers from Johns Hopkins and UTHealth Houston, notably Anish Kumar Mondal, Elisa Carrillo and Vasanthi Jayaraman. The work was supported by the National Institutes of Health, the Searle Scholars Program and the Diana Helis Henry Medical Research Foundation.
Funding: National Institutes of Health (R35GM154904, R35GM122528), the Searle Scholars Program and the Diana Helis Henry Medical Research Foundation.
About this neuroscience research news
Author: Vanessa Wasta
Source: JHU
Contact: Vanessa Wasta – JHU
Image: Image credited to Neuroscience News
Original Research: Open access. “Glutamate gating of AMPA-subtype iGluRs at physiological temperatures” by Edward Twomey et al., published in Nature.
Abstract
Glutamate gating of AMPA-subtype iGluRs at physiological temperatures
Ionotropic glutamate receptors (iGluRs) are tetrameric ligand-gated ion channels that mediate the majority of excitatory neurotransmission in the brain. These receptors open their ion channels in response to glutamate binding, allowing cation influx into postsynaptic neurons and initiating synaptic signaling. However, how full-length iGluRs translate glutamate binding into pore opening has remained incompletely defined.
Using the AMPA-subtype iGluR (AMPAR) as a model, the study identifies the structural mechanism of glutamate-gating at physiological temperatures. AMPAR activation by glutamate is enhanced at body temperature, and by preparing receptors under these conditions for cryo-EM, the investigators captured distinct gating states. Activation involves a conserved motif in which ion channel helices hinge away from the pore axis to open the channel. Desensitization follows local dimer decoupling, allowing the channel hinges to reset and the gate to close. These findings clarify how glutamate gates iGluRs, inform therapeutic design and demonstrate that physiological temperature can influence receptor function.